Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

[1]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[2]  Anthony J. Culyer,et al.  Consolidated Health Economic Evaluation Reporting Standards , 2014 .

[3]  David Moher,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[4]  David Moher,et al.  Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa , 2012, Systematic Reviews.

[5]  P. Scuffham,et al.  Guidelines for conducting and reporting economic evaluation of fall prevention strategies , 2011, Osteoporosis International.

[6]  Iveta Simera,et al.  Describing reporting guidelines for health research: a systematic review. , 2011, Journal of clinical epidemiology.

[7]  Stavros Petrou,et al.  Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting , 2011, BMJ : British Medical Journal.

[8]  Stavros Petrou,et al.  Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting , 2011, BMJ : British Medical Journal.

[9]  D. Moher,et al.  Guidance for Developers of Health Research Reporting Guidelines , 2010, PLoS medicine.

[10]  Isao Kamae,et al.  The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[11]  L. Erickson,et al.  Evidence and Value: Impact on DEcisionMaking – the EVIDEM framework and potential applications , 2008, BMC health services research.

[12]  M. Drummond,et al.  Key principles for the improved conduct of health technology assessments for resource allocation decisions , 2008, International Journal of Technology Assessment in Health Care.

[13]  R. Willke,et al.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[14]  Dan Greenberg,et al.  Quality of Abstracts of Papers Reporting Original Cost-Effectiveness Analyses , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[15]  Andrea Manca,et al.  Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies , 2005, International Journal of Technology Assessment in Health Care.

[16]  Anthony M Vintzileos,et al.  Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics. , 2004, American journal of obstetrics and gynecology.

[17]  C. Bell,et al.  The Quality of Reporting in Published Cost-Utility Analyses, 19761997 , 2000, Annals of Internal Medicine.

[18]  D. Rennie,et al.  Pharmacoeconomic analyses: making them transparent, making them credible. , 2000, JAMA.

[19]  P. Shekelle,et al.  The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. , 1999, Medical care.

[20]  M. Drummond.  A Reappraisal of Economic Evaluation of Pharmaceuticals , 1998, PharmacoEconomics.

[21]  M C Weinstein,et al.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[22]  Milton C. Weinstein,et al.  Recommendations for Reporting Cost-effectiveness Analyses , 1996 .

[23]  T O Jefferson,et al.  Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.

[24]  A. L. Hillman,et al.  Economic Analysis of Health Care Technology: A Report on Principles , 1995, Annals of Internal Medicine.

[25]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[26]  M J Nuijten,et al.  Reporting format for economic evaluation. Part II: Focus on modelling studies. , 1998, PharmacoEconomics.

[27]  M. Drummond.  A reappraisal of economic evaluation of pharmaceuticals. Science or marketing? , 1998, PharmacoEconomics.